Navigation Links
New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
Date:2/1/2009

Chemotherapy is an integral part of modern cancer treatment, but it's not always effective. Successful chemotherapy depends on the ability of anticancer drugs to escape from the bloodstream through the leaky blood vessels that often surround tumors.

Predicting chemotherapy's efficacy could save thousands of individuals from unnecessary toxicity and the often difficult side effects of the treatments.

In a study published in the February issue of the journal Radiology, researchers describe a technique for determining the "leakiness" of tumor blood vessels using a simple digital mammography unit. The researchers designed nanometer-sized capsules containing a contrast agent that could only leak into tumors with blood vessels that were growing and therefore leaky. The digital mammography-based quantification of "leakiness" is closely correlated to the ability of a clinically approved chemotherapy agent to enter the tumor, allowing the researchers to predict the agent's therapeutic efficacy.

"We developed a quantitative way to measure the leakiness of the blood vessels, which is directly linked to the amount of drug that gets to the cancer and in turn determines effectiveness," said Ravi Bellamkonda, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. "By simply measuring how much contrast agent reaches the tumor, we can predict how much of a clinically approved chemotherapeutic will reach the tumor, allowing physicians to personalize the dose and predict effectiveness."

In some cases, one chemotherapy drug may not be effective in treating the tumor, but this new technique allows oncologists to investigate other drugs sooner since they know the drug is reaching the tumor. Studies are currently underway to determine if mammography can predict the optimal dose of a wide range of breast cancer chemotherapeutics.

Bellamkonda and Coulter Department postdoc
'/>"/>

Contact: Abby Vogel
avogel@gatech.edu
404-385-3364
Georgia Institute of Technology Research News
Source:Eurekalert  

1

GOOD

Page: 1 2 3

Related biology news :

1. U of T technique put to use to test clean up of contaminated groundwater
2. New satellite techniques for looking at climate change
3. New computational technique allows comparison of whole genomes as easily as whole books
4. Novel technique changes lymph node biopsy, reduces radiation exposure
5. Novel technique changes lymph node biopsy, reduces radiaiton exposure
6. New technique is quantum leap forward in understanding proteins
7. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
8. Novel technique for fluorescence tomography of tumors in living animals
9. These shells dont clam up: Innovative technique to record human impact on coastal waters
10. Einstein researchers develop technique to count messages made by single genes
11. These shells dont clam up: Innovative technique to record human impact on coastal waters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
(Date:2/8/2010)... offers a wealth of data about how cells respond ... systems is a daunting challenge. In a study ... ), researchers have developed a novel method of interpreting ... biological networks, offering a glimpse into the future of ... been peering through a microscope at cells as they ...
(Date:2/8/2010)... -- With the recent election of Senator Scott ... loss of the Democratic supermajority, the urgency behind broad-based ... for the majority of uninsured Americans has faded dramatically, ... recently noted the country is closer than it has ... a long sought after social reform, and the President ...
(Date:2/8/2010)... cancer is the most common cancer of the female ... is currently no screening method or biomarker to indicate ... malignancy that affects women of all ages" comments paper ... the cells that grow along the inner lining of ... it is diagnosed following patient reports of abnormal bleeding. ...
Breaking Biology News(10 mins):Method of the future uses single-cell imaging to identify gene interactions 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9A potent suppressor of endometrial cancer is revealed 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 1JBFCS Surpasses Fundraising Goal For Hudson Valley Bike Ride Despite Difficult Financial Times 51594 2Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 1Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 2Politicians to Drive on Straw Based Bioethanol at the Climate Change Conference 13014 3
... climate change, Cornell University entomologists show that the social behavior ... period of global warming. , This social evolution occurred ... million to 22 million years ago, compared with the social ... years ago. , "We believe that climatic change was a ...
... new bacterium in an immune-compromised patient, according to a ... belongs to the family Acetobacteraceae and includes bacteria common ... industry, such as vinegar-making. "This is the first ... of the Acetobacteraceae," according to the article. ...
... A new, more robust analysis of recently derived human ... University in St Louis, shows three distinct major waves ... two, and statistically refutes –strongly ?the 'Out of ... of Homo sapiens left Africa 100,000 years ago and ...
Other Biology News:Sociality of sweat bees evolved simultaneously during climate change 2Scientists discover a new disease-causing bacterium in an immune-compromised patient 2New analysis shows three human migrations out of Africa 2
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/6/2010)... University Belfast are developing new sensors to detect chemical ... fight against the threat of terrorist attacks. , The ... individual or crime scene to gather a sample which ... detect the presence of chemicals within seconds. This will ... to terrorist threats. , The scanning instrument will ...
(Date:2/5/2010)... Valencia (UV) has confirmed that the substance used to ... in Morocco, was pine resin. The scientists also studied ... be fragments of material used for iron-working. , In ... a sealed amphora among the remains at Lixus, an ... Morocco. Since then, researchers from the Department of Analytical ...
(Date:2/5/2010)... , Feb. 5 Amicus Therapeutics ... of Directors has elected John F. Crowley ... current role as Chief Executive Officer (CEO), effective immediately. ... , who will become the Lead Independent Director of ... Crowley as Chairman of the Board reflects our confidence ...
Breaking Biology Technology:ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4New technology detects chemical weapons in seconds 2Chemical analyses uncover secrets of an ancient amphora 2Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board 2
... Seventh Study Showing Oncotype DX Frequently Changes Treatment ... Recommendations in Clinical Practice -, ... GHDX ) today announced the publication of results from a ... treat early-stage breast cancer. The study, published in the,October issue ...
... Presented at the Meeting Report the Use of ... Tight Glycemic Control in,Diabetics, MONTVALE, N.J., Nov. ... today announced at the Annual Scientific,Sessions of the ... a,new clinical test to determine haptoglobin (Hp) genotype ...
... WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading developer ... research systems,today highlighted the company,s recent developments and announced ... 30, 2008., Recent Corporate Developments: -- ... awarded a team of researchers ...
Other Biology Technology:Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 2Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 3Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 2Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 3Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 5WaferGen Announces Third Quarter 2008 Financial Results 2WaferGen Announces Third Quarter 2008 Financial Results 3WaferGen Announces Third Quarter 2008 Financial Results 4WaferGen Announces Third Quarter 2008 Financial Results 5WaferGen Announces Third Quarter 2008 Financial Results 6WaferGen Announces Third Quarter 2008 Financial Results 7WaferGen Announces Third Quarter 2008 Financial Results 8WaferGen Announces Third Quarter 2008 Financial Results 9
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...
... This kit #27295 has improved stability and convenience ... kit not only has overcome this problem but ... we have changed the formulation of HRP conjugated ... 1). By this change, the stability of the ...
Biology Products: